-Reuters
Janssen Touts Encouraging Data From Two Ulcerative Colitis Treatments
Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE:JNJ), announced data from an ongoing analysis of a Phase 2a trial of guselkumab…
Related Posts
Why SunCar Technology Shares Are Falling Today
SunCar Technology Group Inc (NASDAQ: SDA) shares are trading lower by around 7% after
Criteo Q2 Bottom-Line Surpass Street View
Criteo S.A. (NASDAQ:CRTO) reported a second-quarter FY22 contribution ex-TAC decline of 3% Y/Y to $215 million, missing the consensus…
Sharps Technology Announces $5.6M Registered Direct And Private Placement Priced At The Market Under Nasdaq Rules
Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has